Patent ID: 7863247

Claim:
A method for reducing a condition associated with fetal alcohol syndrome in a subject who is exposed to alcohol in utero, the method comprising the steps of: (i) selecting a pregnant female having consumed alcohol during pregnancy in an amount sufficient to initiate a condition associated with fetal alcohol syndrome in the subject; and (ii) administering to the subject an activity dependent neurotrophic factor (ADNF) polypeptide in an amount sufficient to reduce in the subject the condition associated with fetal alcohol syndrome, wherein the ADNF polypeptide is a member selected from the group consisting of: (a) an ADNF I polypeptide comprising an active core site having the amino acid sequence Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala (SEQ ID NO:1); (b) an ADNF III polypeptide comprising an active core site having the amino acid sequence Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln (SEQ ID NO:2); and (c) a mixture of the ADNF I polypeptide of (a) and the ADNF III polypeptide of (b).